Instituto Cardiovascular de Linhares

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease2 trials
• Stroke1 trial

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Amgen1 trial
• Hospital Israelita Albert Einstein1 trial

Running trials

• Active, not recruiting

  EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

  NCT05284747· Phase 4· Amgen· Source

Closed trials

• Completed

  Percutaneous Coronary Intervention Followed by Antiplatelet Monotherapy in the Setting of Acute Coronary Syndromes

  NCT04360720· Phase 3· Hospital Israelita Albert Einstein· Source